Time

Event

10:00 am – 2nd Floor

Welcome Remarks
* Sara Jane Demy, Founder & CEO, Demy-Colton

10:30 am – 2nd Floor 

Fireside Chat
How AI will Change the Future of Healthcare   
* Manolis Kellis, Professor of Computer Science, MIT

11:30 am – 12th Floor 

Dialogue 1A
Quantum Computing and Biology: The Convergence Reshaping the Future of Human Health

Moderator: Querida Anderson, Senior Editor, Healthcare, McKinsey Global Publishing

Panel:
* Victoria Lipinska, PhD, Americas Lead for Quantum Innovation Centers, IBM

11:30 am – Rooftop 

Dialogue 1B
The Future of Psychedelics: Interventions for Mental Health 

Moderator: Virginia Amann, Founder, ENTENTE Network

12:30 pm – 2nd Floor 

“Big Think" Plenary Session
Tackling the Hard Questions: Policy, PBMs, The IRA

Moderator: Jennifer Hawks Bland, CEO, NewYorkBIO

Panel:
* Nouhad Husseini, SVP, Head of Business Development & Corporate Strategy, Regeneron Pharmaceuticals
* Philippe Lopes-Fernandes, Executive Vice President, Chief Business Officer, Ipsen
* Neal Masia, PhD, Co-Founder, CEO, EntityRisk
* Peter Rubin, Executive Director, No Patient Left Behind

1:30 pm – 12th Floor 

Luncheon

2:30 pm – 2nd Floor 

Presenting Companies 

2:30 pm – 12th Floor

One-to-One Meetings

4:30 pm – 12th Floor 

Dialogue 2A

Pioneering Bioethics: Navigating the Frontiers of Cognitive Liberty, Privacy, and Innovative Therapeutics
This panel will examine the ethical implications of emerging neurotechnologies that can potentially alter or augment cognitive function, enhance brain-sensing technology, and diagnose disease. The panel will address the question of balancing privacy and innovation.

Moderator: Walter Greenleaf, PhD, Neuroscientist & Product Developer, Stanford University

Panel:
* Kurt Haggstrom, Chief Commercial Officer, Synchron
* Brent Vaughan, Founder & Leader at the Intersection of Tech & Biotech

4:30 pm – Rooftop 

Dialogue 2B
New Frontiers in Autoimmune Disease: It’s Not What You Think

Moderator: Laurence Blumberg, MD, Lecturer, Weill Cornell Medicine

Panel: 
* David de Graaf, PhD, Co-Founder, CEO & President, Reverb Therapeutics
* Matthew Harrison, Managing Director, Head of Biotech Industry Research, Morgan Stanley
* Lawrence Steinman, MD, Zimmermann Professor of Neurology & Neurological Sciences, and Pediatrics, Beckman Center for Molecular Medicine, Stanford University (via Zoom) 
* Geeta Vemuri, PhD, Founder & Managing Partner, Agent Capital

 

5:30 pm – 2nd Floor 

End of Day “Big Think” Plenary Session
Navigating New Horizons: Unlocking Opportunities in TechBio
The session will delve into the emerging opportunities in the TechBio sector, examining how technological advancements are revolutionizing biological research and applications including drug discovery tools, advances in personalized medicine, streamlining clinical trials and enhancing disease diagnosis and management. Panelists will discuss the current trends and future prospects in TechBio, investment strategies in this rapidly evolving field and the challenges and potential solutions in bringing TechBio innovations to market.

Moderator: Seth Flaum, Partner, Wilson Sonsini 

Panel:
* Daniella Kranjac, Founding GP, Avant Bio
* Ajit Singh, PhD, Partner, Artiman Ventures

6:30 pm – Rooftop 

Evening Reception